{
  "topic": "Mechanism of Action of Ciclosporin",
  "questions": [
    {
      "question": "What is the primary mechanism of action of ciclosporin?",
      "options": [
        "Inhibition of T-cell activation by blocking calcineurin",
        "Inhibition of DNA synthesis in rapidly dividing cells",
        "Blockade of interleukin-2 (IL-2) receptors",
        "Inhibition of purine synthesis"
      ],
      "answer": "Inhibition of T-cell activation by blocking calcineurin"
    },
    {
      "question": "Which intracellular protein does ciclosporin bind to in order to exert its immunosuppressive effects?",
      "options": [
        "Calcineurin",
        "Cyclophilin",
        "FK-binding protein (FKBP)",
        "mTOR"
      ],
      "answer": "Cyclophilin"
    },
    {
      "question": "What is the primary effect of ciclosporin on T-cells?",
      "options": [
        "Promotes T-cell proliferation",
        "Inhibits T-cell activation and IL-2 production",
        "Enhances antigen presentation by dendritic cells",
        "Increases cytotoxic T-cell activity"
      ],
      "answer": "Inhibits T-cell activation and IL-2 production"
    },
    {
      "question": "Which of the following cytokines is most directly affected by ciclosporin?",
      "options": [
        "Interleukin-1 (IL-1)",
        "Interleukin-2 (IL-2)",
        "Interleukin-6 (IL-6)",
        "Tumor necrosis factor-alpha (TNF-Î±)"
      ],
      "answer": "Interleukin-2 (IL-2)"
    },
    {
      "question": "What is the role of calcineurin in T-cell activation?",
      "options": [
        "It promotes the transcription of IL-2 and other cytokines",
        "It inhibits the nuclear factor of activated T-cells (NFAT)",
        "It enhances antigen presentation by dendritic cells",
        "It increases the production of cytotoxic T-cells"
      ],
      "answer": "It promotes the transcription of IL-2 and other cytokines"
    },
    {
      "question": "Which of the following is a common clinical use of ciclosporin in veterinary medicine?",
      "options": [
        "Treatment of bacterial infections",
        "Management of immune-mediated diseases (e.g., atopic dermatitis)",
        "Prevention of viral replication",
        "Treatment of fungal infections"
      ],
      "answer": "Management of immune-mediated diseases (e.g., atopic dermatitis)"
    },
    {
      "question": "What is the primary molecular target of ciclosporin in the calcineurin pathway?",
      "options": [
        "Nuclear factor of activated T-cells (NFAT)",
        "Cyclophilin",
        "FK-binding protein (FKBP)",
        "mTOR"
      ],
      "answer": "Cyclophilin"
    },
    {
      "question": "Which of the following is a potential side effect of ciclosporin therapy?",
      "options": [
        "Hyperglycemia",
        "Nephrotoxicity",
        "Bone marrow suppression",
        "Hypokalemia"
      ],
      "answer": "Nephrotoxicity"
    },
    {
      "question": "How does ciclosporin affect the nuclear factor of activated T-cells (NFAT)?",
      "options": [
        "It promotes the translocation of NFAT to the nucleus",
        "It inhibits the dephosphorylation and activation of NFAT",
        "It enhances the binding of NFAT to DNA",
        "It increases the production of NFAT"
      ],
      "answer": "It inhibits the dephosphorylation and activation of NFAT"
    },
    {
      "question": "Which of the following drugs has a similar mechanism of action to ciclosporin but binds to FK-binding protein (FKBP) instead of cyclophilin?",
      "options": [
        "Tacrolimus",
        "Sirolimus",
        "Mycophenolate mofetil",
        "Azathioprine"
      ],
      "answer": "Tacrolimus"
    }
  ]
}